2015
DOI: 10.1242/dev.123729
|View full text |Cite
|
Sign up to set email alerts
|

The melanocyte lineage in development and disease

Abstract: There was an error published in Development 142, 620-632.The affiliations were incorrectly linked to the second and third authors. The authors appear with their correct affiliations above.The authors apologise to readers for this mistake. 1387

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
186
0
9

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 168 publications
(198 citation statements)
references
References 105 publications
3
186
0
9
Order By: Relevance
“…It is estimated that more than seventy thousand melanoma cases were diagnosed in 2014 in the United States (2) and is still rapidly increasing compared to any other solid tumors (3). Over the past years, some progress has been made in surgery removal, chemotherapy and radiotherapy (4,5). However, the incidence and mortality rate have been increasing for higher recurrence and metastasis.…”
Section: Introductionmentioning
confidence: 99%
“…It is estimated that more than seventy thousand melanoma cases were diagnosed in 2014 in the United States (2) and is still rapidly increasing compared to any other solid tumors (3). Over the past years, some progress has been made in surgery removal, chemotherapy and radiotherapy (4,5). However, the incidence and mortality rate have been increasing for higher recurrence and metastasis.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the creation of mouse-human NC chimeras represents a novel experimental platform to investigate NC-associated human diseases under in vivo conditions. It will be particularly attractive to use this experimental platform to study NC-derived tumors (28,29). Because tumor formation is clonal, it should be possible to study initiation, progression, and manifestation of the tumors under in vivo conditions, even if donor cell contribution is low.…”
Section: Discussionmentioning
confidence: 99%
“…An NCC origin for AML and LAM cells has been largely favored 14,15,17 because of their coexpression of melanocytic and smooth cell markers, two cell lineages known to arise either fully, in the case of melanocytes, 38 or partially, in the case of smooth muscle cells, 39 from NCCs. However, because TSC2 down-regulated all the NCC markers expressed by TSC2 À cells without inducing the expression of NCC precursor markers, our findings were inconsistent with AML arising from NCCs.…”
Section: Discussionmentioning
confidence: 99%